Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dscamtm1Pfu mutation
(1 available);
any
Dscam mutation
(105 available)
Opn4tm1(cre)Sapa mutation
(0 available);
any
Opn4 mutation
(33 available)
|
|
|
vision/eye
|
• fasiculation and spacing phenotype in melanopsin positive RGCs
|
nervous system
|
• fasiculation and spacing phenotype in melanopsin positive RGCs
|
|
• fasiculation and spacing phenotype in melanopsin positive RGCs
|
cellular
|
• fasiculation and spacing phenotype in melanopsin positive RGCs
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dscamtm1Pfu mutation
(1 available);
any
Dscam mutation
(105 available)
Tg(Pax6-cre,GFP)2Pgr mutation
(1 available)
|
|
|
vision/eye
|
• dopaminergic amacrine cells and neurites are clumped
• disorganization is seen in all portions of the inner nuclear layer, even where cre is inactive
• cholinergic amacrine cell lamination is impaired in portions of the retina where cre is active in all retinal neurons
|
|
• melanopsin-positive RGCs are fasciculated and aggregated in the peripheral retina, but not in the central or dorsal retina
|
nervous system
|
• of retinal dopaminergic and bNOS positive amacrine cell neurites
|
|
• dopaminergic amacrine cells and neurites are clumped
• disorganization is seen in all portions of the inner nuclear layer, even where cre is inactive
• cholinergic amacrine cell lamination is impaired in portions of the retina where cre is active in all retinal neurons
|
|
• melanopsin-positive RGCs are fasciculated and aggregated in the peripheral retina, but not in the central or dorsal retina
|
cellular
|
• of retinal dopaminergic and bNOS positive amacrine cell neurites
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dscamtm1Pfu mutation
(1 available);
any
Dscam mutation
(105 available)
Tg(CAG-cre/Esr1*)5Amc mutation
(9 available)
|
|
|
vision/eye
|
• following tamoxifen treatment at E13 or E16 dopaminergic amacrine cells and neurites are clumped
|
|
• following tamoxifen treatment at P0
|
|
• following tamoxifen treatment at P0 2?3 fasciculated groups of melanopsin positive retinal ganglion cells are seen in each retina
|
nervous system
|
• following tamoxifen treatment at E13 or E16 dopaminergic amacrine cells and neurites are clumped
• following tamoxifen treatment at P0, 2?3 fasciculated groups of retinal ganglion cells are seen in each retina
• however with tamoxifen treatment at P0 or in adults no fasiculation of amacrine cell neurites is seen
|
|
• following tamoxifen treatment at E13 or E16 dopaminergic amacrine cells and neurites are clumped
|
|
• following tamoxifen treatment at P0
|
|
• following tamoxifen treatment at P0 2?3 fasciculated groups of melanopsin positive retinal ganglion cells are seen in each retina
|
cellular
|
• following tamoxifen treatment at E13 or E16 dopaminergic amacrine cells and neurites are clumped
• following tamoxifen treatment at P0, 2?3 fasciculated groups of retinal ganglion cells are seen in each retina
• however with tamoxifen treatment at P0 or in adults no fasiculation of amacrine cell neurites is seen
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dscamtm1Pfu mutation
(1 available);
any
Dscam mutation
(105 available)
Tg(Thy1-cre)1Vln mutation
(1 available)
|
|
|
vision/eye
|
• aggregation of recombined retinal ganglion cells
|
nervous system
|
• aggregation of recombined retinal ganglion cells
|
vision/eye
|
• recombined but not non-recombined dopaminergic amacrine cells and neurites are clumped
|
nervous system
|
• recombined but not non-recombined dopaminergic amacrine cells and neurites are clumped
|
|
• recombined but not non-recombined dopaminergic amacrine cells and neurites are clumped
|
cellular
|
• recombined but not non-recombined dopaminergic amacrine cells and neurites are clumped
|